| Literature DB >> 32472219 |
Fuchuang Zhang1, Bingjie Liu1, Qiaodan Deng1, Dandan Sheng1, Jiahui Xu1, Xueyan He1, Lixing Zhang2, Suling Liu3.
Abstract
Uncoupling protein 1 (UCP1) has been implicated in ameliorating metabolic related disorders, of which most symptoms are risk factors for breast cancer. Here, we found that UCP1 was obviously downregulated in basal-like breast cancer (BLBC) and was positively correlated with improved survival. However, the underlying regulatory mechanisms remain largely unknown. Our studies showed that UCP1 inhibited tumor progression via suppressing aldehyde dehydrogenase (ALDH)-positive breast cancer stem cell (BCSC) population in BLBC. Furthermore, we found that UCP1 induced the upregulation of fructose bisphosphatase 1 (FBP1) which was previously blocked by Snail overexpression, and UCP1 decreased ALDH-positive BCSCs via FBP1-dependent metabolic rewiring, which could be reversed by Snail overexpression. In addition, breast cancer cells co-cultured with UCP1-deficient adipocytes had increased proportion of ALDH-positive BCSCs, indicating a potential protection role of UCP1 in tumor microenvironment. These results suggested that UCP1 suppressed BCSCs through inhibiting Snail-mediated repression of FBP1, and that upregulation of UCP1 might be a previously undescribed therapeutic strategy for combating breast cancer. Graphical abstract.Entities:
Keywords: BCSC; Breast cancer; FBP1; UCP1
Mesh:
Substances:
Year: 2020 PMID: 32472219 DOI: 10.1007/s10565-020-09533-5
Source DB: PubMed Journal: Cell Biol Toxicol ISSN: 0742-2091 Impact factor: 6.691